Aquestive Therapeutics
AQST
AQST
60 hedge funds and large institutions have $96.5M invested in Aquestive Therapeutics in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
+3
Holders Change %
+5.26%
% of All Funds
1.21%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
22
Reduced
16
Closed
11
Calls
$270K
Puts
$1.32M
Net Calls
-$1.05M
Net Calls Change
-$1.18M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$3.05M |
| 2 |
Morgan Stanley
New York
|
+$2.85M |
| 3 |
Charles Schwab
San Francisco,
California
|
+$618K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$615K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$588K |
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
-$1.38M |
| 2 |
Squarepoint
New York
|
-$942K |
| 3 |
BlackRock
New York
|
-$756K |
| 4 |
Millennium Management
New York
|
-$749K |
| 5 |
BBVA
Banco Bilbao Vizcaya Argentaria
Madrid,
Spain
|
-$196K |
